Vanguard Group Inc Kodiak Sciences Inc. Transaction History
Vanguard Group Inc
- $6.44 Trillion
- Q3 2025
A detailed history of Vanguard Group Inc transactions in Kodiak Sciences Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 1,950,292 shares of KOD stock, worth $38.1 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,950,292
Previous 1,822,301
7.02%
Holding current value
$38.1 Million
Previous $6.8 Million
369.71%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding KOD
# of Institutions
128Shares Held
44.4MCall Options Held
213KPut Options Held
224K-
Baker Bros. Advisors LP New York, NY17.3MShares$338 Million2.31% of portfolio
-
Black Rock Inc. New York, NY3.85MShares$75.1 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct2.84MShares$55.4 Million0.09% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA1.34MShares$26 Million0.04% of portfolio
-
Iconiq Capital, LLC San Francisco, CA1.27MShares$24.7 Million0.53% of portfolio
About Kodiak Sciences Inc.
- Ticker KOD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,040,200
- Market Cap $1.02B
- Description
- Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...